FREIA - Fetal Risk & Embryotoxicity Information service Aarhus: A unique work tool to optimize fetal drug safety during pregnancy

Our research

Advising pregnant women on the risks and benefits of medication is difficult due to insufficient fetal safety information.

FREIA combines data on all singleton pregnancies in the Central Denmark Region (covering 1/5 of Denmark’s population), identified from electronic charts and linked on an individual level. Information on medication exposure and outcomes (pregnancy, birth, and neonatal) are provided by the electronic patient records of the women and children.

An interface provides access to this information with filters that allow for queries customized to specific clinical questions.
FREIA provides daily updated clinical information on drug safety in pregnancy. The underlying data can form the backbone of future automated surveillance systems.

Projects

• Prototype FREIA
• Nationwide FREIA

Funding

Collaborations

Nationwide FREIA project

• Per Damkair, MD Clinical pharmacologist, PhD, Professor
• Jon Trærup Andersen, MD Clinical pharmacologist, PhD, Professor
• Tine Brink Henriksen, MD Neonatologist, PhD, Professor
• Business intelligence office, Central Denmark Region